Noxopharm Annual Report 2022

Noxopharm Limited 62 Substantial holders Substantial holders in the company are set out below: Ordinary shares % of total shares Number held issued MILLIGENE PTY LTD (THE GE + PR KELLY FAM TRUST) AND OTHERS 35,649,106 12.20% ELEANORE GOODRIDGE 14,121,085 4.83% Voting rights The voting rights attached to ordinary shares are set out below: Ordinary shares On a show of hands every member present at a meeting in person or by proxy shall have one vote and upon a poll each share shall have one vote. Options All quoted and unquoted options do not carry any voting rights. There are no other classes of equity securities. ASX Listing Rule 3.13.1 and 14.3 The Company advises that the Annual General Meeting (AGM) of the Company is scheduled for Thursday 17 November 2022 at 1.00pm (AEDT). The location of the AGM is subject to COVID-19 restrictions, including regulatory requirements. Further details, including any hybrid or virtual meeting arrangements, will be confirmed closer to the AGM. Further to Listing Rule 3.13.1, Listing Rule 14.3, nominations for election of directors at the AGM must be received not less than 30 Business Days before the meeting, being no later than Wednesday 6 October 2022.

RkJQdWJsaXNoZXIy MjE2NDg3